IP Library › Assignment 025950/0048
Patent Assignment
Reel/Frame 025950/0048

Patent Security Release Agreement

Recorded: 2011-03-14 Received: 2011-03-14 Pages: 25
Assignor
GOLDMAN SACHS LENDING PARTNERS LLC
Executed: 2011-03-08
Assignees
VALEANT PHARMACEUTICALS INTERNATIONAL
ONE ENTERPRISE, ALISO VIEJO, CA, 92656, UNITED STATES
VALEANT PHARMACEUTICALS NORTH AMERICA
ONE ENTERPRISE, ALISO VIEJO, CA, 92656, UNITED STATES
CORIA LABORATORIES, LTD.
3801 HULEN ST., FORT WORTH, TX, 76107, UNITED STATES
DOW PHARMACEUTICAL SCIENCES, INC.
1330 REDWOOD WAY, PETALUMA, CA, 94954, UNITED STATES
ATON PHARMA, INC.
3150 BRUNSWICK PIKE, STE. 130, LAWRENCEVILLE, NJ, 08648, UNITED STATES
Covered Properties (75)
Azithromycin for the treatment of nodular acne
Application: 12/799,401 →
N-(4-(6-Fluoro-3,4-Dihydroisoquinolin-2(1H)-Yl)-2,6-Dimethylphenyl)-3,3-Dimethylbutanamide as Potassium Channel Modulators
Application: 12/698,070 →
Modified Release Formulation and Methods of Use
Application: 12/691,680 →
Modified Release Formulation and Methods of Use
Application: 12/690,889 →
Stereoselective Synthesis of Metyrosine
Application: 61/256,926 →
Ocular Drug Delivery Devices
Application: 61/256,915 →
Aqueous compositions containing metronidazole
Application: 12/589,680 →
Method for obtaining a stable dispersion of benzoyl peroxide
Application: 12/589,236 →
Modified Release Formulation and Methods of Use
Application: 12/505,409 →
Benzyloxy Anilide Derivatives Useful as Potassium Channel Modulators
Application: 12/491,055 →
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Application: 12/455,525 →
Imiquimod formulation
Application: 12/319,978 →
Silicone Gel-Based Compositions for Wound Healing and Scar Reduction
Application: 12/242,681 →
Azithromycin for Treatment of Skin Disorders
Application: 12/231,586 →
Derivatives of 5-Amino-4,6-Disubstituted Indole and 5-Amino-4,6-Disubstituted Indoline as Potassium Channel Modulators
Application: 12/189,709 →
Naphthyridine Derivatives as Potassium Channel Modulators
Application: 12/181,126 →
Uses of Trientine and Penicillamine as Countermeasures to Metal Contamination
Application: 12/180,130 →
Modified Release Formulation and Methods of Use
Application: 61/082,162 →
Benzyloxy Anilide Derivatives Useful as Potassium Channel Modulators
Application: 61/075,307 →
3-Hydroxyisothiazole-4-Carboxamidine Derivatives as CHK2 Inhibitors
Application: 12/143,672 →
Derivatives of 4-(N-Azacycloalkyl) Anilides as Potassium Channel Modulators
Application: 12/138,251 →
Method for increasing the solubility of betacyclodextrin
Application: 12/072,578 →
Method for Stabilizing Polypeptides Lacking Methionine
Application: 12/069,745 →
Methods and Compositions for Increasing Solubility of Azole Drug Compounds That Are Poorly Soluble in Water
Application: 12/012,413 →
Drug Delivery System for Administering an Adjustable Preset Dose
Application: 12/014,739 →
Compositions and methods for treating diseases of the nail
Application: 12/006,531 →
Controlled Release Azithromycin Solid Dosages Forms
Application: 12/002,417 →
1,4 Diamino Bicyclic Retigabine Analogues as Potassium Channel Modulators
Application: 11/946,822 →
N-[2-Amino-4-(Phenylmethoxy)Phenyl] Amides and Related Compounds as Potassium Channel Modulators
Application: 11/870,368 →
Silicone gel-based compositions for wound healing and scar reduction
Application: 60/997,166 →
Azithromycin for the Treatment of Nodular Acne
Azithromycin for treatment of skin disorders
Application: 60/967,504 →
Derivatives of 4-(N-Azacycloalkyl) Anilides as Potassium Channel Modulators
Application: 11/894,877 →
Derivatives of 1,3-diamino benzene as potassium channel modulators
Application: 11/893,724 →
Derivatives of 5-amino-4 6-disubstituted indole and 5-amino-4 6-disubstituted indoline as potassium channel modulators
Application: 60/964,526 →
Naphthyridine derivatives as potassium channel modulators
Application: 60/962,862 →
Topical Acne Vulgaris Medication with a Sunscreen
Application: 11/823,385 →
3-Hydroxyisothiazole-4-carboxamidine derivatives as Chk2 inhibitors
Application: 60/936,720 →
Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel modulators
Application: 60/934,396 →
Substituted Arylamino -1,2,3,4-Tetrahydro Naphthalenes and -2,3-Dihydro-1H-Indenes as Potassium Channel Modulators
Application: 11/810,114 →
Silicone based emulsions for topical drug delivery
Application: 11/699,906 →
Two-phase mucoadhesive composition
Application: 11/654,921 →
Azithromycin for the Treatment of Nodular Acne
Application: 11/635,127 →
1,4 Diamino Bicyclic Retigabine Analogues as Potassium Channel Activators
Application: 60/867,482 →
N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel activators
Application: 60/850,867 →
N-[2-amino-4-(phenylmethoxy)phenyl]carbamic acid esters and related compounds as potassium channel activators
Application: 60/851,084 →
Azithromycin for the treatment of nodular acne
Application: 60/849,065 →
Derivatives of 4-(N-azacycloalkyl) anilides as potassium channel activators
Application: 60/839,941 →
Derivatives of 3-(N-azacycloalkyl) anilides as potassium channel activators
Application: 60/839,642 →
Derivatives of 1,3-diamino benzene as potassium channel activators
Application: 60/838,808 →
Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
Application: 60/833,886 →
Alpha Hydroxy Acid Sustained Release Formulation
Application: 11/490,896 →
Substituted arylamino -1,2,3,4-tetrahydro naphthalenes and -2,3-dihydro-1H-indenes as KCNQ activators
Application: 60/811,463 →
Use of a clobetasol spray formulation to treat psoriasis
Application: 11/408,105 →
Topical Acne Vulgairs Medication with a Sunscreen
Application: 11/393,981 →
2-Beta-Modified-6-Substituted Adenosine Analogs and Their Use as Antiviral Agents
Application: 10/530,627 →
Novel Heterocyclic Compounds Having Anti-Hbv Activity
Application: 11/347,145 →
Synthesis and Use of 2'-Substituted-N6-Modified Nucleosides
Application: 10/542,235 →
Single-enantiomer n-(4-bromo-or-3-tri-fluoromethyl)phenyl-thiazolidinones, oxazolidinones and pyrrolidinones for HBV
Application: 60/706,602 →
Single-enantiomer thiazolidinones, oxazolidinones, and pyrrolidinones for HBV
Application: 60/701,819 →
3', 5'-Cyclic nucleotide analogs for treatment of HCV infection
Application: 60/681,332 →
Phosphoramidate prodrugs of 2'-methyl ribonucleotides
Application: 60/678,636 →
Aqueous Compositions Containing Metronidazole
Application: 11/037,430 →
Quinoxaline Derivatives Having Antiviral Activity
Application: 10/826,439 →
Combinations of Retigabine and Sodium Channel Inhibitors or Sodium Channel-Influencing Active Compounds for Treating Pains
Application: 10/727,655 →
Heterocyclic Compounds and Uses Thereof
Application: 10/455,149 →
Antiviral Phosphonate Compounds and Methods Therefor
Application: 10/426,507 →
Drug Delivery System for Administering an Adjustable Preset Dose
Application: 10/367,626 →
Nucleoside Compounds and Uses Thereof
Application: 10/318,476 →
Nucleoside Analogs with Carboxamidine Modified Monocyclic Base
Application: 10/227,235 →
Tirazole Nucleoside Analogs and Methods for Using Same
Application: 10/095,665 →
Skin Cream
Application: 10/094,534 →
Topical Gel Delivery System
Application: 10/096,516 →
Aqueous Compositions Containing Metronidazole
Application: 10/033,835 →
Skin Cleanser Comprising a Steareth, Poloxamer and a Glyceryl Monoester
Application: 09/802,047 →